Jennison Associates LLC Has $45.10 Million Stock Holdings in Celldex Therapeutics, Inc. (NASDAQ:CLDX)
Jennison Associates LLC trimmed its position in Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 16.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,329,095 shares of the biopharmaceutical company’s stock after selling 252,995 shares during the quarter. Jennison […]
More Stories
Axxcess Wealth Management LLC Purchases 434 Shares of EQT Corporation (NYSE:EQT)
Axxcess Wealth Management LLC boosted its position in EQT Corporation (NYSE:EQT – Free Report) by 7.0% during the first quarter,...
EQT Corporation (NYSE:EQT) Shares Sold by DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale reduced its position in EQT Corporation (NYSE:EQT – Free Report) by 0.9% in the 1st quarter, HoldingsChannel.com...
Western Digital (NASDAQ:WDC) Given New $85.00 Price Target at Morgan Stanley
Western Digital (NASDAQ:WDC – Get Free Report) had its target price hoisted by research analysts at Morgan Stanley from $78.00...
James Bye Net Worth 2025: Career, Awards, & Personal Life
British actor James Bye is known popularly for his role as Martin Fowler in EastEnders. Born in Basingstoke, he has...
Pennie Loans Review 2025: Is Try Pennie Legit or a Scam?
Before writing this Pennie Loans review, I have gone through their website multiple times. What I have understood is that...
JPMorgan Chase & Co. (NYSE:JPM) Shares Sold by Hourglass Capital LLC
Hourglass Capital LLC cut its holdings in JPMorgan Chase & Co. (NYSE:JPM) by 6.1% during the 1st quarter, Holdings Channel...